Navigation Links
Frost & Sullivan Recognizes Cytomedix for its Pioneering System that Supports the Emerging Regenerative Therapies Market
Date:3/6/2013

inion leaders are regularly using, researching, publishing and presenting on advances in treatment methodologies, physicians want the flexibility to experiment with different formulations," noted Frost & Sullivan Research Analyst Aarti Shetty . "The Angel cPRP system allows physicians to generate customized platelet concentrates at the point of care by adjusting the concentration and volume levels for different indications from spinal surgery to knee replacement."

Another potential area of application for Angel cPRP is in controlling inflammation and alleviating pain. For instance, the options for a patient with a sports trauma injury can range between a temporary solution such as hyaluronic acid and corticosteroids to major surgery, like total joint replacement. Angel cPRP has the ability to fit in between these large extremes as an alternative solution. This application can have far-reaching effects and will provide much-needed help to thousands of patients in the future.

With many physicians already using the Angel cPRP system, Cytomedix is carefully analyzing all the data from the current usage to design appropriate clinical trials for procedure-specific formulations. Products such as these will have revolutionary effects on the regenerative technologies market.

"Currently, Angel cPRP is used with non-bioactive materials such as bone graft substitutes to create a biologically active environment for bone growth," observed Shetty. "This represents a huge market, and Angel cPRP shows great potential for excellent penetration in this viable market. The value that can be derived from a heterogeneous population of cells is far greater than that which can be derived from single cells like some bone graft products."

Going forward, Frost & Sullivan expects to see more physicians and surgeons adopting Angel cPRP and its formulations as the market moves toward more personalized medicine. In recognition of it
'/>"/>

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Frost & Sullivan: Government Support Vital to Encourage Venture Capital Investments in the North American Healthcare Industry
2. Product Differentiation to Boost European Human Growth Hormones Market, Says Frost & Sullivan
3. Frost & Sullivan Recognizes KAERs Game-Changing Innovating Aerosol Drug Delivery Methods for High-Dose Respiratory Disease Therapeutics
4. Frost & Sullivan Recognizes GenePOCs Growth Backed by Strong Leadership and Technology Excellence
5. Frost & Sullivan Accolade for Swissrays Exceptional Dedication to its Customers
6. Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan
7. Frost & Sullivan: Clinical Trial-based Evidence Vital to Obtain Venture Capital Funding for Wireless Patient Monitoring Technologies
8. Frost & Sullivan Acknowledges that PKCs Biosensors are Expected to Become the New Industry Standard in Pathogen Testing
9. Increasing Surgical Volumes to Boost Use of Tissue Sealants and Topical Haemostats, Says Frost & Sullivan
10. Frost & Sullivan: Digitisation of Australias healthcare system met with widespread apprehension
11. Frost & Sullivan Recognizes ResearchDx for Its Impressive Performance in the Companion Diagnostics Sector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... LOS ANGELES , Sept. 19, 2014  CytRx ... and development company specializing in oncology, today announced that ... will present at BioCentury,s 2014 NewsMakers in the Biotech ... p.m. Eastern Time. The conference will take place at ... City . A live and archived ...
(Date:9/19/2014)... -- Reductions in kidney failure obtained during ... with diabetes type 2 "Intensive treatment is ... kidneys." Australian researchers have discovered that intensive ... to persistent reductions in kidney failure many years after ... has found that, five and a half years after ...
(Date:9/18/2014)... , September 19, 2014 ... Markets ( http://www.researchandmarkets.com/research/qqjrnh/global_molecular ) has announced the ... Market 2014-2018" report to their offering. ... Cytogenetics involves the study of chromosomes using ... functions of genes and chromosomes. It plays ...
Breaking Medicine Technology:CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 2ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 3Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 2Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 3
(Date:9/20/2014)... (PRWEB) September 20, 2014 New ... and Market Analysis to 2023?. The asthma market ... as it has become saturated with relatively efficacious ... corticosteroids (ICSs), inhaled corticosteroids and long-acting beta-agonists (ICS/LABAs), ... increasing generic competition. However, the launch of seven ...
(Date:9/20/2014)... Recently, Best Cheap Hosting USA (best-cheap-hosting-usa.com), a ... website. The new site provides the latest reviews ... customers. Here, people can find a lot of ... it has recommended some excellent web hosting suppliers ... great web hosting suppliers, InMotion ( http://www.best-cheap-hosting-usa.com/go/InMotion/ ), ...
(Date:9/20/2014)... September 20, 2014 "As a nurse, patients ... tanks," said an inventor from Tamaqua, Pa. "The reason that ... the backs of their chairs. My invention enables them to ... Kam Oxygen Sensor to make it easier to monitor the ... user knows when the tank is low. It allows changeovers ...
(Date:9/20/2014)... Earlier this week, Home Depot revealed that up to ... card information pilfered by hackers, surpassing the 40 million Target ... articles like this one published by Bloomberg on September ... , “Most people tend to focus on how many credit ... score a game,” says Joe Caruso, founder and CEO/CTO of ...
(Date:9/20/2014)... September 20, 2014 Final Cut Pro ... the release of the Information theme for FCPX filmmakers. , ... to describe the Information theme,” says Christina Austin, CEO of ... look so professional.” , Information features easy to use controls ... of the environment. Change the background color, color of each ...
Breaking Medicine News(10 mins):Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 3Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 4Health News:Best Cheap Hosting USA Launches Its New Website And Recommends InMotion To Worldwide People 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 3Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 4Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 5Health News:Today Pixel Film Studios Announced the Release of the Information Theme for Final Cut Pro X 2
... to the latest on breast-feeding, there is no hard and ... newborn. Most young mothers would be more// than glad ... while breast feeding, can prove too painful for motherly feelings ... Adolphe. Nicola accordingly, had a horrendous time trying to breastfeed ...
... prince donates his youth to his father so that he could ... is at hand now. For scientists say they have discovered a ... by manipulating that gene perhaps one could live longer, they hope. ... lifespan of animals that are subjected to a calorie-restricted diet -when ...
... Anti-depressants could indeed lift one out of depression. But ... been recognized//. ,Now the U.S. Food and ... antidepressant medications update the existing black box warning on ... of suicidal thinking and behavior, in young adults ages ...
... pregnancy, migraine and stroke, US researchers said. The combination ... fact, Cheryl Bushnell, assistant professor of neurology at the ... that pregnant women who suffered migraine carried a risk ... did not suffer migraine. ,Elaborating on the ...
... know that older women - those 80 or older - have ... published today. ,Worryingly, the research also found that 56 ... breast cancer risk. ,The strongest risk factor for breast ... higher her risk. About one in 70 women will develop breast ...
... of moderate to severe chronic obstructive pulmonary disease//, or ... ,The results of the randomized, double-blind, placebo-controlled trial of ... May American Journal of Respiratory and Critical Care Medicine, ... to an editorial commenting on the research, the failure ...
Cached Medicine News:Health News:New Research Promises To Take The Pain Off Breast Feeding 2Health News:New Research Promises To Take The Pain Off Breast Feeding 3Health News:Gene Responsible for Ageing Process Discovered – and Calorie Restriction Could Hel 2Health News:FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too 2Health News:FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too 3Health News:Women Unaware of When Breast Cancer Risk is Greatest 2Health News:Anti-inflammatory Drug Fails to Improve COPD Symptoms 2
Human based material available in two levels for the control of accuracy and precision for upto 23 analytes....
Human based assayed sera available in three levels for the control of accuracy and precision for up to 25 analytes...
The AMY method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of amylase activity in serum, plasma and urine....
Enzymatic Clearance assay for the in vitro quantitative determination of LDL-cholesterol in human serum and plasma....
Medicine Products: